Found 3,739 clinical trials

S Scott Damrauer

PCSK9i in AAA1

Please see section 3 of the full protocol Please see section 3 of the full protocol Please see section 3 of the full protocol

99 years and younger All Phase N/A

S Scott Damrauer

PCSK9i in AAA1

Please see section 3 of the full protocol Please see section 3 of the full protocol Please see section 3 of the full protocol

99 years and younger All Phase N/A

Q Q3 A3

PCSK9i in AAA1

Please see section 3 of the full protocol Please see section 3 of the full protocol Please see section 3 of the full protocol

99 years and younger All Phase N/A

Q Q3 A3

PCSK9i in AAA1

Please see section 3 of the full protocol Please see section 3 of the full protocol Please see section 3 of the full protocol

99 years and younger All Phase N/A

I Investigator 1

This study is looking for individuals 18 to 65 years old with PKU. Sanofi believes that everyoneshould have the opportunity to take part in clinical trials. It is important to include people whohave been historically under-represented in clinical trials. Sanofi is committed to inclusivity inour studies.If you are interested in …

100 years and younger All Phase 1

d dfdfdfdf

22 Sep 2023 -24

Please see section 3 of the full protocol Please see section 3 of the full protocol Please see section 3 of the full protocol

99 years and younger All Phase N/A

F Ferner Ben

22 Sep 2023 -241

Please see section 3 of the full protocol Please see section 3 of the full protocol Please see section 3 of the full protocol

99 years and younger All Phase N/A

A Aysegul ISLER DALGIC, Prof. Dr.

The Effect of Yoga on Gaining Sleep Habits in Children

This study was planned to determine the effect of the "Little Yogis Doing Yoga" Program, which will be created within the scope of the research, on getting children aged 5-6 years old to sleep habits. This study was planned in a pretest, posttest design, follow-up, randomized controlled study. The sample …

5-6 years All Phase N/A

D Daniel Yu

Sujana-A Phase 1/Phase 2 open-label study to evaluate the safety, tolerability, and efficacy of a single intravenous administration of an investigational medication in adult participants with phenylketonuria (PKU)

100 years and younger All Phase N/A

I Investigator 1

Check for regression on Sites Management

Checking for Check for regression on Sites Management

10-90 years All Phase 4